Is an early diagnosis of CLL beneficial in its treatment?
Mechanism of action of venetoclax (ABT-199) and its side effects
The goals and work of the European Research Initiative on CLL (ERIC)
A free market and data-driven approach to solve the issue of drug cost
How to explain the 'watch-and-wait' period to a CLL patient?